Silver Leaf During Pregnancy in French Guiana : Use and Impact on Health

NCT06538753 | Completed

• 1 other identifier: Fey darjan
• Study Type: observational
• Target: 332
• Locations: 1 country
• Sites: 1

Brief Summary

This is a descriptive, observational, cross-sectional study among women who have given birth in one of French Guiana's maternity hospitals to determine if the use of silver leaf is frequent and could have an impact on pregancy outcomes. This Fey darjan project is an ancillary study of the Nutri Pou Ti'Moun 1 project

Conditions

Pregnancy Complications; Herbal Medicine Adverse Reaction

Keywords

Pregnancy; Traditional medecine use; Traditional medecine adverse reaction; Silver leaf; French Guiana

Outcome Measures

Primary Outcomes (1)

• Prevalence of silver leaf decoction use

  To estimate the prevalence of silver leaf decoction use among women who gave birth in one of the French Guiana maternity hospitals assessed by a questionnaire

  At inclusion

Secondary Outcomes (5)

• Description of pregnancy outcomes

  At inclusion

• Description of immediate post-partum outcomes

  At inclusion

• Description of delivery pain management method

  At inclusion

• Use and representations of women using SLDs

  At inclusion

• Health professionals comprehensions on SLDs use during delivery

  At inclusion

Eligibility Criteria

• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Pregnant women delivering in one of the French Guiana maternity hospitals and previously included in study Nutri Pou Ti Moun 1

You may qualify if:

• Women admitted for delivery in one of the French Guiana maternity hospitals and previsouly included in the study Nutri Pou Ti Moun 1 (NCT05653128)

You may not qualify if:

• Refusal to participate to study or absence of collection of non-opposition of participant
• Lack of parental consent for minor participants
• Women under gardianship or curatorship

Sponsors & Collaborators

• Centre Hospitalier de Cayenne: lead

Study Sites (1)

Centre Hospitalier de Cayenne

Cayenne, 97300, French Guiana

Location

Related Publications (4)

• Chang CW, Ko FN, Su MJ, Wu YC, Teng CM. Pharmacological evaluation of ocoteine, isolated from Cassytha filiformis, as an alpha 1-adrenoceptor antagonist in rat thoracic aorta. Jpn J Pharmacol. 1997 Mar;73(3):207-14. doi: 10.1254/jjp.73.207.

  PMID: 9127815 BACKGROUND

• Antonio ADS, Aguiar ATC, Dos Santos GRC, Pereira HMG, da Veiga-Junior VF, Wiedemann LSM. Phytochemistry by design: a case study of the chemical composition of Ocotea guianensis optimized extracts focused on untargeted metabolomics analysis. RSC Adv. 2020 Jan 21;10(6):3459-3471. doi: 10.1039/c9ra10436d. eCollection 2020 Jan 16.

  PMID: 35497754 BACKGROUND

• Antonio AS, Veiga-Junior VF, Wiedemann LSM. Ocotea complex: A metabolomic analysis of a Lauraceae genus. Phytochemistry. 2020 May;173:112314. doi: 10.1016/j.phytochem.2020.112314. Epub 2020 Feb 29.

  PMID: 32120118 BACKGROUND

• Guterres Zda R, da Silva AF, Garcez WS, Garcez FR, Fernandes CA, Garcez FR. Mutagenicity and recombinagenicity of Ocotea acutifolia (Lauraceae) aporphinoid alkaloids. Mutat Res. 2013 Sep 18;757(1):91-6. doi: 10.1016/j.mrgentox.2013.07.004. Epub 2013 Jul 24.

  PMID: 23892138 BACKGROUND

Related Links

• Traditional pharmacopoeia in Frecnh Guiana
• Plants of love : ethnobotany of plant species used for sexual purposes in Afro-descendant communities in French Guiana
• The hybrid pharmacopoeias of French Guiana : ethnobotany of a phytotherapy on the move

MeSH Terms

Conditions

Pregnancy Complications

Condition Hierarchy (Ancestors)

Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases

Study Officials

• Celia BASURKO, MD

  Centre Hospitalier de Cayenne

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 18, 2024
• First Posted: August 6, 2024
• Study Start: March 21, 2023
• Primary Completion: July 7, 2023
• Study Completion: July 7, 2023
• Last Updated: August 6, 2024

Record last verified: 2024-07

Locations

FR (1)